RNA polymerase is an enzyme that is responsible for copying a DNA sequence into an RNA sequence, duyring the process of transcription. As complex molecule composed of protein subunits, RNA ...
Doctors have long believed the cancer drug 5-fluorouracil works by damaging the building blocks of DNA, but researchers have now found that in certain cancers, it kills cells by interfering with RNA ...
Gene expression is linked to RNA transcription, which cannot happen without RNA polymerase. However, this is where the similarities between prokaryote and eukaryote expression end. Central to the ...
Since the 1950s, a chemotherapy drug known as 5-fluorouracil has been used to treat many types of cancer, including blood ...
RNA polymerase (RNAP) is a type of protein that produces mRNA. It tracks processively along double helical DNA, untwists it ...
By Dr. Sushama R. Chaphalkar, PhD. A new deep learning model, LucaProt, has detected over 251,000 new RNA virus species from ...
The global mRNA synthesis and manufacturing market is projected to grow from USD 624.4 million in 2024 to USD 738.3 million by 2029, at a CAGR of 3.4%. Key drivers include the growing focus on ...
To find RNA viruses hiding in genomic ā€œdark matter,ā€ researchers took advantage of one thing they all have in common: the RNA polymerase enzyme.
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribeā„¢ RNA Polymerase, a novel enzyme that reduces double ...
GlobalDataā€™s report assesses the drugs in the DNA Directed RNA Polymerase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
Applied DNA Sciences, Inc. (NASDAQ:APDN) (ā€Applied DNAā€), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in ...
TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribeā„¢ RNA ...